Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2
- PMID: 3001697
- PMCID: PMC390911
- DOI: 10.1073/pnas.82.24.8340
Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2
Abstract
Human apolipoprotein B-100 (apo B-100) is the major apolipoprotein of low density lipoproteins and the principal ligand for interaction with the low density lipoprotein receptor. The human apo B-100 gene has been inserted into a lambda gt-11 expression vector, and the apo B-100 cDNA clones have been identified by screening with a monospecific apo B-100 antiserum, by screening with synthetic oligonucleotides based on the amino acid sequence of peptides isolated from apo B-100, and by immunoblot analysis of the expressed protein with a monoclonal antibody to apo B-100. The complete nucleotide and derived-amino acid sequence of a 1.7-kilobase cDNA clone of apo B-100 was determined. The 560-amino acid residues of apo B-100 contain no unique linear or repeating sequences of amino acids. The computer-predicted conformation of the apo B-100 protein contains segments of helical structure; however, a large portion of the protein is organized into beta-structure. The beta-structure may be important in lipid-apo B-100 interactions in low density lipoprotein and may contribute to the insolubility of delipidated apo B-100 in aqueous buffers. RNA blot hybridization analysis of liver mRNA utilizing a Nco I/HindIII apo B-100 cDNA probe revealed that the apo B-100 mRNA is 15-18 kilobases long, which is of sufficient size to code for a 250-387 kDa apolipoprotein, the proposed molecular size of delipidated plasma apo B-100. The gene for human apo B-100 has been localized to chromosome 2 by filter hybridization of human-mouse somatic cell hybrids utilizing a 400-base-pair Nco I/HindIII apo B-100 cDNA probe. This location is in contrast to the low density lipoprotein receptor that has been localized to chromosome 19. The cloning of human apo B-100 has provided new insights into the structure and physicochemical properties of apo B-100 and will facilitate studies on the factors modulating apo B-100 biosynthesis and the expression of the apo B-100 gene in patients with dyslipoproteinemias.
Similar articles
-
A new approach for studying gene regulation by distant DNA elements in transgenic mice.Scand J Clin Lab Invest Suppl. 1999;229:33-9. doi: 10.1080/00365519950185931. Scand J Clin Lab Invest Suppl. 1999. PMID: 10097288 Review.
-
Apolipoprotein B mRNA editing: a key controlling element targeting fats to proper tissue.Ann Med. 1993 Dec;25(6):539-43. Ann Med. 1993. PMID: 8292303 Review.
-
A partial cDNA clone for human apolipoprotein B.Proc Natl Acad Sci U S A. 1985 Aug;82(15):4983-6. doi: 10.1073/pnas.82.15.4983. Proc Natl Acad Sci U S A. 1985. PMID: 3860836 Free PMC article.
-
Molecular cloning of human LDL apolipoprotein B cDNA. Evidence for more than one gene per haploid genome.Atherosclerosis. 1985 Dec;58(1-3):277-89. doi: 10.1016/0021-9150(85)90073-5. Atherosclerosis. 1985. PMID: 3841481
-
Isolation, expression and characterization of a human apolipoprotein B 100-specific cDNA clone.Biol Chem Hoppe Seyler. 1986 Oct;367(10):1077-83. doi: 10.1515/bchm3.1986.367.2.1077. Biol Chem Hoppe Seyler. 1986. PMID: 3024665
Cited by
-
Low-density lipoprotein: a versatile nanoscale platform for targeted delivery.Nanoscale Adv. 2023 Jan 24;5(4):1011-1022. doi: 10.1039/d2na00883a. eCollection 2023 Feb 14. Nanoscale Adv. 2023. PMID: 36798503 Free PMC article. Review.
-
Association of CELSR2, APOB100, ABCG5/8, LDLR, and APOE polymorphisms and their genetic risks with lipids among the Thai subjects.Saudi J Biol Sci. 2023 Feb;30(2):103554. doi: 10.1016/j.sjbs.2022.103554. Epub 2022 Dec 26. Saudi J Biol Sci. 2023. PMID: 36619676 Free PMC article.
-
Genetic Polymorphisms in a Familial Hypercholesterolemia Population from North-Eastern Europe.J Pers Med. 2022 Mar 9;12(3):429. doi: 10.3390/jpm12030429. J Pers Med. 2022. PMID: 35330428 Free PMC article.
-
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690. Metabolites. 2021. PMID: 34677405 Free PMC article. Review.
-
Early pregnancy dyslipidemia is associated with placental DNA methylation at loci relevant for cardiometabolic diseases.Epigenomics. 2020 Jun;12(11):921-934. doi: 10.2217/epi-2019-0293. Epub 2020 Jul 17. Epigenomics. 2020. PMID: 32677467 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous